Acute tubular necrosis (ATN) is a type of renal azotemia caused by damage to the kidney tubules, leading to cell death. Ischemia, sepsis, heavy metals, and medications can…
Dana V. Rizk, MD, professor of medicine, University of Alabama at Birmingham; and Gerald Appel, MD, professor of medicine and co-director of the Center for Glomerular Disease, Columbia…
NEW YORK (Reuters Health) – For localized renal tumors, partial nephrectomy confers a survival advantage and a lower risk of severe chronic kidney disease (CKD) after surgery, relative…
NEW YORK (Reuters Health) – In patients with type 2 diabetes, intensive control of blood sugar reduces the risk of microalbuminuria and macroalbuminuria, but its impact on hard…
NEW YORK (Reuters Health) – Active surveillance (“watchful waiting”) of small renal masses offers short term results equivalent to those with immediate surgery, researchers from UK report in…
NEW YORK (Reuters Health) – Pooled data suggest that use of renin–angiotensin system (RAS) inhibitors, particularly angiotensin converting enzyme (ACE) inhibitors may increase the risk of angioedema, researchers…
NEW YORK (Reuters Health) – In a large randomized study of hemodialysis patients with new arteriovenous grafts, daily fish oil supplementation didn’t improve long-term graft patency. However, those…
NEW YORK (Reuters Health) – Older patients with small localized kidney tumors treated with partial nephrectomy live longer than those treated with radical nephrectomy, a new study suggests.…
NEW YORK (Reuters Health) – A population-based study conducted in Canada has uncovered an association between starting fibrate therapy and an increase in serum creatinine in older patients,…
NEW YORK (Reuters Health) – Kidney transplant recipients who are inoculated with autologous marrow-derived mesenchymal stem cells (MSC) have less risk of organ rejection and of opportunistic infection…
NEW YORK (Reuters Health) – Tight glycemic control in preterm babies who develop hyperglycemia should be avoided for now, until more data on the risks and benefits are…
NEW YORK (Reuters Health) – Early ischemic events are reduced in patients undergoing percutaneous coronary intervention for acute coronary syndrome when they’re treated with cangrelor rather than clopidogrel…
